Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33623141

FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2021 May
First author
Brown PA

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Leukemia. 2021 May;35(5):1527. doi: 10.1038/s41375-021-01245-x.
    note
    Source null
    related pmid
    33846544
    relationship
    Erratum in

Authors and identifiers

  1. name
    Brown PA
    type
    Author
  2. name
    Kairalla JA
    type
    Author
  3. name
    Hilden JM
    type
    Author
  4. name
    Dreyer ZE
    type
    Author
  5. name
    Carroll AJ
    type
    Author
  6. name
    Heerema NA
    type
    Author
  7. name
    Wang C
    type
    Author
  8. name
    Devidas M
    type
    Author
  9. name
    Gore L
    type
    Author
  10. name
    Salzer WL
    type
    Author
  11. name
    Winick NJ
    type
    Author
  12. name
    Carroll WL
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Brown PA
    type
    Author
  2. name
    Kairalla JA
    type
    Author
  3. name
    Hilden JM
    type
    Author
  4. name
    Dreyer ZE
    type
    Author
  5. name
    Carroll AJ
    type
    Author
  6. name
    Heerema NA
    type
    Author
  7. name
    Wang C
    type
    Author
  8. name
    Devidas M
    type
    Author
  9. name
    Gore L
    type
    Author
  10. name
    Salzer WL
    type
    Author
  11. name
    Winick NJ
    type
    Author
  12. name
    Carroll WL
    type
    Author
bibliography ids
  1. nci-bib-4a87ce6933d2975e279c82f0
book metadata
content sha256
def982406b877fbb22358e573d9569ecc7d494e32884e79a13c52aac2f86046b
document type
citation
dois
  1. 10.1038/s41375-021-01177-6
electronic publication date
display
2021 Feb 23
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:33623141
immutable id
pubmed:33623141@def982406b877fbb22358e573d9569ecc7d494e32884e79a13c52aac2f86046b
journal
abbreviation
Leukemia
issn electronic
1476-5551
issn print
0887-6924
issue
5
name
Leukemia
nlm unique id
8704895
pages
1279-1290
volume
35
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Leukemia. 2021 May;35(5):1527. doi: 10.1038/s41375-021-01245-x.
    note
    Source null
    related pmid
    33846544
    relationship
    Erratum in
outcomes validated
false
pmid
33623141
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
ad5e8d582bd6c72a845fdbfdef15802b0d6b6c0659775b2045c19d9a36272d74
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 May
precision
month
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Research Support, N.I.H., Extramural
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33623141/
title
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.

Preserved source evidence · Not medical advice